» Articles » PMID: 38001913

Chemical Transdifferentiation of Somatic Cells: Unleashing the Power of Small Molecules

Overview
Journal Biomedicines
Date 2023 Nov 25
PMID 38001913
Authors
Affiliations
Soon will be listed here.
Abstract

Chemical transdifferentiation is a technique that utilizes small molecules to directly convert one cell type into another without passing through an intermediate stem cell state. This technique offers several advantages over other methods of cell reprogramming, such as simplicity, standardization, versatility, no ethical and safety concern and patient-specific therapies. Chemical transdifferentiation has been successfully applied to various cell types across different tissues and organs, and its potential applications are rapidly expanding as scientists continue to explore new combinations of small molecules and refine the mechanisms driving cell fate conversion. These applications have opened up new possibilities for regenerative medicine, disease modeling, drug discovery and tissue engineering. However, there are still challenges and limitations that need to be overcome before chemical transdifferentiation can be translated into clinical practice. These include low efficiency and reproducibility, incomplete understanding of the molecular mechanisms, long-term stability and functionality of the transdifferentiated cells, cell-type specificity and scalability. In this review, we compared the commonly used methods for cell transdifferentiation in recent years and discussed the current progress and future perspective of the chemical transdifferentiation of somatic cells and its potential impact on biomedicine. We believe that with ongoing research and technological advancements, the future holds tremendous promise for harnessing the power of small molecules to shape the cellular landscape and revolutionize the field of biomedicine.

Citing Articles

Direct fibroblast reprogramming: an emerging strategy for treating organic fibrosis.

Lin H, Wang X, Chung M, Cai S, Pan Y J Transl Med. 2025; 23(1):240.

PMID: 40016790 PMC: 11869441. DOI: 10.1186/s12967-024-06060-3.


Bacterial Ribosomes Induce Plasticity in Mouse Adult Fibroblasts.

Datta A, Istiaq A, Tamura S, Ohta K Cells. 2024; 13(13.

PMID: 38994968 PMC: 11240311. DOI: 10.3390/cells13131116.


Exploring Stem-Cell-Based Therapies for Retinal Regeneration.

Radu M, Branisteanu D, Pirvulescu R, Dumitrescu O, Ionescu M, Zemba M Life (Basel). 2024; 14(6).

PMID: 38929652 PMC: 11204673. DOI: 10.3390/life14060668.

References
1.
Yoo A, Sun A, Li L, Shcheglovitov A, Portmann T, Li Y . MicroRNA-mediated conversion of human fibroblasts to neurons. Nature. 2011; 476(7359):228-31. PMC: 3348862. DOI: 10.1038/nature10323. View

2.
OConnor R, Cesano A, Kreider B, Lange B, Clark S, Nowell P . Growth factor-dependent differentiation along the myeloid and lymphoid lineages in an immature acute T lymphocytic leukemia. J Immunol. 1990; 145(11):3779-87. View

3.
Tang W, Guo R, Shen S, Zheng Y, Lu Y, Jiang M . Chemical cocktails enable hepatic reprogramming of human urine-derived cells with a single transcription factor. Acta Pharmacol Sin. 2018; 40(5):620-629. PMC: 6786299. DOI: 10.1038/s41401-018-0170-z. View

4.
Ramalingam S, Annaluru N, Kandavelou K, Chandrasegaran S . TALEN-mediated generation and genetic correction of disease-specific human induced pluripotent stem cells. Curr Gene Ther. 2014; 14(6):461-72. DOI: 10.2174/1566523214666140918101725. View

5.
Treutlein B, Lee Q, Camp J, Mall M, Koh W, Shariati S . Dissecting direct reprogramming from fibroblast to neuron using single-cell RNA-seq. Nature. 2016; 534(7607):391-5. PMC: 4928860. DOI: 10.1038/nature18323. View